PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 17.30% | 7.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.30% | 7.48% | |||
| Cost of Revenue | 16.08% | 8.74% | |||
| Gross Profit | 18.18% | 6.59% | |||
| SG&A Expenses | 4.26% | -15.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.29% | -11.53% | |||
| Operating Income | 1.88% | 21.79% | |||
| Income Before Tax | 8.86% | 11.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.86% | 11.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.86% | 11.79% | |||
| EBIT | 1.88% | 21.79% | |||
| EBITDA | 1.83% | 23.05% | |||
| EPS Basic | 8.82% | 11.69% | |||
| Normalized Basic EPS | 2.56% | 18.75% | |||
| EPS Diluted | 8.82% | 11.69% | |||
| Normalized Diluted EPS | 2.56% | 18.75% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
